New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Homology Medicines, Inc.
FIXX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3M

Biotechnology

Next Earning date - 12 Nov 2024

3M

Biotechnology

Next Earning date - 12 Nov 2024

0.93USD
Shape0.01 ( 0.77%)
favorite-chart

Relative Strenght

1
favorite-chart

Volume Buzz

1259%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

96%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M % 3M % 1Y -95.28 %

Key Metrics

Shape
  • Market Cap

    3.02M


  • Shares Outstanding

    3.23M


  • Share in Float

    2.04M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.9347


  • Average Volume

    29535


  • Beta

    -0.107


  • Range

    0.9-26.64


  • Industry

    Biotechnology


  • Website

    https://www.homologymedicines.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.70x

P/S Ratio

0.02x

P/B Ratio

0.2

Debt/Equity

-4688.9%

Net Margin

$-35.1

EPS

How FIXX compares to sector?

P/E Ratio

Relative Strength

Shape

FIXX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$0.70

Shape-168%

2025-EPS

$2M

Shape87%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Credit Suisse

initialise

Previous: Not converted

2022-04-28

Now: Neutral

RBC Capital

downgrade

Previous: Not converted

2022-02-22

Now: Sector Perform

Oppenheimer

downgrade

Previous: Not converted

2022-02-22

Now: Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.51
vs -0.54

Q3.22

arrow
arrow

N/A

-0.59
vs -0.54

Q4.22

arrow
arrow

N/A

-0.60
vs -0.59

Q1.23

arrow
arrow

N/A

-0.50
vs -0.20

Q2.23

arrow
arrow

N/A

-0.61
vs -0.51

Q3.23

arrow
arrow

N/A

-0.57
vs -0.59

Q4.23

arrow
arrow

N/A

-0.24
vs -0.60

Q1.24

arrow
arrow

N/A

-0.50
vs -0.50

Q3.24

arrow
arrow

N/A

-0.17
vs -0.57

Q4.24

arrow
arrow

N/A

-0.15
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-63%

802K  vs 2.2M

Q3.22

arrow
arrow

-52%

802K  vs 1.7M

Q4.22

arrow
arrow

NA

802K  vs 802K

Q1.23

arrow
arrow

NA

802K  vs 802K

Q2.23

arrow
arrow

-56%

354K  vs 802K

Q3.23

arrow
arrow

-100%

NA  vs 802K

Q4.23

arrow
arrow

+77%

1.4M  vs 802K

Q1.24

arrow
arrow

-100%

NA  vs 802K

Q3.24

arrow
arrow

NA

500K  vs NA

Q4.24

arrow
arrow

-65%

500K  vs 1.4M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-12%

-0.12
vs 0.35

Q3.22

arrow
arrow

-15%

-0.15
vs -0.12

Q4.22

arrow
arrow

-19%

-0.19
vs -0.15

Q1.23

arrow
arrow

-19%

-0.19
vs -0.19

Q2.23

arrow
arrow

-29%

-0.29
vs -0.19

Q3.23

arrow
arrow

-37%

-0.37
vs -0.29

Q4.23

arrow
arrow

-22%

-0.22
vs -0.37

Q1.24

arrow
arrow

+2%

0.02
vs -0.22

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

81

81
vs 103

-21%

Q3.22

arrow
arrow

78

78
vs 81

-4%

Q4.22

arrow
arrow

81

81
vs 78

4%

Q1.23

arrow
arrow

64

64
vs 81

-21%

Q2.23

arrow
arrow

60

60
vs 64

-6%

Q3.23

arrow
arrow

59

59
vs 60

-2%

Q4.23

arrow
arrow

58

58
vs 59

-2%

Q1.24

arrow
arrow

1

1
vs 58

-98%

Earnings Growth

Latest News